tiprankstipranks
Advertisement
Advertisement

CPRX Stock Latest News

Catalyst Pharma Gains FTC Clearance for Angelini Merger
Company AnnouncementsCatalyst Pharma Gains FTC Clearance for Angelini Merger
2d ago
8K
CPRX
Catalyst Pharmaceuticals Sets July 2026 Vote on $31.50-per-Share Angelini Pharma Buyout
PremiumCompany Announcements
Catalyst Pharmaceuticals Sets July 2026 Vote on $31.50-per-Share Angelini Pharma Buyout
17d ago
CPRX
Catalyst Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Catalyst Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
28d ago
CPRX
Catalyst Pharmaceuticals reports Q1 non-GAAP EPS 79c, consensus 64c
PremiumThe Fly
Catalyst Pharmaceuticals reports Q1 non-GAAP EPS 79c, consensus 64c
2M ago
CPRX
Catalyst Pharmaceuticals not providing forward-looking guidance
PremiumThe Fly
Catalyst Pharmaceuticals not providing forward-looking guidance
2M ago
CPRX
Catalyst Pharma Reports Higher Revenue, Suspends Earnings Guidance
PremiumCompany AnnouncementsCatalyst Pharma Reports Higher Revenue, Suspends Earnings Guidance
2M ago
8K
CPRX
CPRX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CPRX Upcoming Earnings Report: What to Expect?
2M ago
CPRX
Catalyst Pharmaceuticals downgraded to Neutral from Buy at Citi
Premium
The Fly
Catalyst Pharmaceuticals downgraded to Neutral from Buy at Citi
2M ago
CPRX
Catalyst Pharmaceuticals downgraded to Neutral from Outperform at Baird
PremiumThe Fly
Catalyst Pharmaceuticals downgraded to Neutral from Outperform at Baird
2M ago
CPRX
Catalyst Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
PremiumThe Fly
Catalyst Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
2M ago
CPRX
Catalyst Pharma Settles Firdapse Patent Litigation With Hetero
PremiumCompany Announcements
Catalyst Pharma Settles Firdapse Patent Litigation With Hetero
2M ago
8K
CPRX
Catalyst Pharmaceuticals downgraded to Equal Weight from Overweight at Stephens
PremiumThe Fly
Catalyst Pharmaceuticals downgraded to Equal Weight from Overweight at Stephens
2M ago
CPRX
Catalyst Pharmaceuticals to be acquired by Angelini Pharma for $31.50 per share
PremiumThe FlyCatalyst Pharmaceuticals to be acquired by Angelini Pharma for $31.50 per share
2M ago
BX
CPRX
Analyst Initiates Buy on Catalyst Pharma, Citing M&A Appeal, Rare Disease Growth and $35 Price Target Backed by Strong Balance Sheet
Premium
Ratings
Analyst Initiates Buy on Catalyst Pharma, Citing M&A Appeal, Rare Disease Growth and $35 Price Target Backed by Strong Balance Sheet
2M ago
CPRX
Angelini exploring acquisition of Catalyst Pharmaceuticals, Bloomberg says
Premium
The Fly
Angelini exploring acquisition of Catalyst Pharmaceuticals, Bloomberg says
2M ago
CPRX
Catalyst Pharmaceuticals trading resumes
PremiumThe Fly
Catalyst Pharmaceuticals trading resumes
2M ago
CPRX
Catalyst Pharmaceuticals trading halted, volatility trading pause
PremiumThe Fly
Catalyst Pharmaceuticals trading halted, volatility trading pause
2M ago
CPRX
Catalyst Pharma Patent Trial Against Hetero USA Delayed
PremiumCompany Announcements
Catalyst Pharma Patent Trial Against Hetero USA Delayed
3M ago
8K
CPRX
Catalyst Pharmaceutical Partners Signals Confident Growth Path
PremiumCompany Announcements
Catalyst Pharmaceutical Partners Signals Confident Growth Path
4M ago
CPRX
Buy Rating on Catalyst Pharma Driven by Strong 2026 Growth Outlook and Favorable Firdapse Litigation Upside
PremiumRatingsBuy Rating on Catalyst Pharma Driven by Strong 2026 Growth Outlook and Favorable Firdapse Litigation Upside
4M ago
CPRX
Catalyst Pharmaceuticals price target raised to $35 from $33 at Citi
Premium
The Fly
Catalyst Pharmaceuticals price target raised to $35 from $33 at Citi
4M ago
CPRX
Buy Rating on Catalyst Pharma Backed by Strong Growth, Underpenetrated LEMS Opportunity, and Rising Profitability Post-Royalty Roll-Off
Premium
Ratings
Buy Rating on Catalyst Pharma Backed by Strong Growth, Underpenetrated LEMS Opportunity, and Rising Profitability Post-Royalty Roll-Off
4M ago
CPRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >